Gloved hands handling a lab plate with a pipette.

Biotech + pharma hub

Connect research, talent and industry in a globally recognized life sciences ecosystem, with expertise spanning R&D, manufacturing and commercialization.

over 
400

biotech companies active in R&D

# 
1

World’s most innovative economy for 16 consecutive years

CHF 
2.6
 billion

invested in Swiss biotech in 2025

Switzerland’s life sciences ecosystem brings together pharmaceutical companies, biotech firms, startups and leading research institutions. Companies can access expertise and partners across the value chain, from R&D and advanced manufacturing to commercialization, within a strategically located European business environment.

Why Switzerland

Urban landscape with modern buildings under a clear blue sky.

Ecosystem 

Switzerland brings together global pharmaceutical companies, innovative biotech firms, specialized SMEs, startups and leading research institutions in a connected life sciences ecosystem. Companies can access experienced partners across the value chain, from R&D and manufacturing to licensing and commercialization. With its central location, advanced infrastructure, and efficient logistics, Switzerland supports streamlined and cost-effective supply chain management across Europe and beyond.

European Union flags waving in front of a modern glass building.

Regulatory

Strong intellectual property protection, internationally recognized quality standards and established regulatory expertise provide a reliable environment for knowledge-intensive companies. Switzerland supports biotech and pharmaceutical businesses in developing, protecting and bringing innovations to market. Switzerland has one of the highest numbers of biotech patents per capita, thanks to its straightforward and effective IP registration system.

Person working at a desk in a sunlit office with mountain view.

Innovation

Leading universities and research institutions work closely with industry to turn scientific discoveries into commercial applications. Technology transfer, collaborative R&D and targeted innovation support help companies advance new products and technologies. When it comes to clinical trials and drug development, Switzerland contributes more to the global clinical trial pipeline per capita than any other country.

Scientist in protective gear working in a lab through glovebox ports.

Talent 

Switzerland attracts and develops highly qualified scientific, technical and managerial talent. Leading universities, established life sciences companies and an international working environment give businesses access to the expertise they need to establish and grow their operations. Consistently ranked #1 in INSEAD’s Global Talent Competitiveness Index, Switzerland is widely regarded as the most attractive destination for qualified international professionals and executives.

Biotech + pharma innovation in Switzerland

Sophia Genetics

Sophia Genetics, based in the Canton of Vaud, was founded in 2011 as a spin-off of EPFL. Through its AI platform it established the world’s largest data-driven medicine community network and now serves more than 750 institutions worldwide

Show more

BC Platforms

BC Platforms is a global leader in healthcare data management, analytics, and access. The company has global operations with its headquarters in Zurich, Switzerland, is partnered by over 90 hospitals, biobanks, and research centers globally, and reaches over all continents.

Show more

Geneva University Hospital

Geneva University Hospital became the first hospital in Europe to utilize IBM’s AI technology Watson to optimize therapeutic options for patients.

Show more

Incyte

Incyte, a U.S.-based biopharma company, focuses on treatments in oncology, inflammation, and autoimmunity, with its European headquarters and a manufacturing site in Switzerland.

Show more

Organon & Co.

The U.S. company Organon & Co focuses on women’s health and established its international HQ for marketing, quality, supply chain management, and commercial functions in Lucerne.

Show more

Lonza

Lonza, headquartered in Basel, is a global leader in pharma and biotech manufacturing, offering services from drug development to large-scale production. In Visp (Valais), the company is investing CHF 650 million to build a next-generation mammalian facility.

Show more

Publications

Download more resources

Contact

Man in a dark suit smiling, standing before a geometric white cube background.

David Dixon

Senior Consultant - Investment Promotion

Renens, Switzerland

ddixon@s-ge.com

+41 21 545 94 98

Log in or register

Enter your email to continue.

Exclusive access for companies based in Switzerland or the Principality of Liechtenstein.